Home CONTACT Neoplasma 2015 Neoplasma Vol.62, No.1, p.146-151, 2015

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.62, No.1, p.146-151, 2015

Title: Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experienc
Author: T. SZOTKOWSKI, E. FABER, J. HUBACEK, L. RAIDA, P. ROHON, A. KUBA, Z. PIKALOVA, M. HOLZEROVA, M. DIVOKA, M. JAROSOVA, J. VRBKOVA, T. PAPAJIK, K. INDRAK

Abstract: Acute promyelocytic leukemia is a unique entity among acute leukemias. Introduction of all-trans retinoic acid and, subsequently, arsenic trioxide in its treatment has markedly improved treatment outcomes for this once frequently fatal disease. Improved outcomes have also been observed in elderly patients, including those in whom standard intensive therapy is contraindicated because of comorbidities.
In our center, a total of 60 APL patients were treated in 1993-2013, of whom 9 were aged 60 or more years. Although most of them had significant comorbidities at the time of diagnosis, eight achieved complete remission. At the time of the analysis, six patients were alive and in long-term remission; two patients died of causes other than APL. The median follow-up was 59 months.
Included is case report of a patient with a high comorbidity score whose treatment was markedly reduced and individualized.
Our experience shows that, in APL patients a curative approach is generally tolerated and should always be attempted regardless of age and comorbidities.

Keywords: APL – elderly patients – comorbidity
Published online: 17-Oct-2014
Year: 2015, Volume: 62, Issue: 1 Page From: 146, Page To: 151
doi:10.4149/neo_2015_019


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.